Quantcast

Latest Body fluids Stories

2014-07-15 08:29:13

MARIETTA, Ga., July 15, 2014 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, processor and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that its results for the second quarter, ended June 30, 2014, will be released before the opening of the market on Tuesday, July 29, 2014. MiMedx will host a live broadcast of its second quarter conference call on Tuesday, July 29, 2014, at...

2014-06-04 12:29:13

MARIETTA, Ga., June 4, 2014 /PRNewswire/ -- The Board of Directors of MiMedx Group, Inc. (NASDAQ: MDXG), announced today that the Board applauds the dismissal of the lawsuit brought by the Securities and Exchange Commission ("SEC") against the Company's Chairman and CEO, Parker H. "Pete" Petit. The SEC had brought a civil action against Mr. Petit alleging that in 2007, when he was Chairman and CEO of Matria Healthcare, Inc. (NASDAQ: MATR), he provided inside information to a friend...

2014-05-23 08:24:51

MARIETTA, Ga., May 23, 2014 /PRNewswire/ -- MiMedx (NASDAQ: MDXG), an integrated developer, processor and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that it will present at the Jefferies 2014 Healthcare Conference in New York, New York. Parker H. "Pete" Petit, Chairman and CEO, William C. Taylor, President and COO, and Michael J. Senken, Chief Financial Officer, are scheduled to present on Tuesday,...

2014-05-15 08:32:43

MARIETTA, Ga., May 15, 2014 /PRNewswire/ -- MiMedx (NASDAQ: MDXG), an integrated developer, processor and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that it will present at the 11(th) Annual Craig-Hallum Institutional Investor Conference in Minneapolis, Minnesota. Parker H. "Pete" Petit, Chairman and CEO, William C. Taylor, President and COO, and Michael J. Senken, Chief Financial Officer, are...

2014-05-08 08:33:14

IRVING, Texas, May 8, 2014 /PRNewswire-USNewswire/ -- Glyceryl guaiacolate ether (GGE) is unlikely to make it easier to cough up phlegm when delivered in the recommended dose. GGE is approved by the FDA as an over-the-counter expectorant and is the active ingredient in Mucinex extended-release and many other cold remedies on the market. The study was published in the May 2014 issue of RESPIRATORY CARE, a journal of the American Association for Respiratory Care. A total of 295 subjects...

2014-04-22 08:33:34

MARIETTA, Ga., April 22, 2014 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent-protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that it has filed a patent infringement lawsuit against Liventa Bioscience, Inc. ("Liventa"), Medline Industries, Inc. ("Medline") and Musculoskeletal Transplant Foundation, Inc. ("MTF") for permanent injunctive relief and unspecified...

2014-04-11 23:24:30

Salimetrics launches new, easy-to-use website with streamlined navigation and enhanced educational resources, as part of Salimetrics focus of helping researchers incorporate saliva into interdisciplinary sciences. (PRWEB) April 11, 2014 Salimetrics, the provider of world-class saliva-based tools and services, invites users to explore the newly redesigned website, http://www.salimetrics.com. Now streamlined with enhanced features, researchers and users alike can benefit from more...

2014-04-02 16:31:06

MARIETTA, Ga., April 2, 2014 /PRNewswire/ -- MiMedx (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that its results for the first quarter ended March 31, 2014, will be released before the opening of the market on Friday, April 25, 2014. MiMedx will host a live broadcast of its first quarter conference call on Friday, April 25, 2014 at 10:30am EDT....

2014-03-28 16:22:35

MARIETTA, Ga., March 28, 2014 /PRNewswire/ -- MiMedx (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today that it will present at the 13(th) Annual Needham Healthcare Conference in New York, New York. Parker H. "Pete" Petit, Chairman and CEO, William C. Taylor, President and COO, and Michael J. Senken, Chief Financial Officer, are scheduled to present...

2014-03-25 23:35:42

Since its inception in 1998, Salimetrics has long been a leader in developing innovative assays for use in salivary research and diagnostic applications. Salimetrics now aims to partner with SalivaBio to distribute innovative saliva collection devices. (PRWEB) March 25, 2014 Founded in 2010, SalivaBio is an industry newcomer with deep roots in salivary bioscience, matched with strong device manufacturing and engineering know-how. As the list of analytes available in saliva expands,...


Word of the Day
bibliopole
  • A bookseller; now, especially, a dealer in rare and curious books.
This word comes from a Greek phrase meaning 'book seller.'
Related